Progress in Neuro-Psychopharmacology and Biological Psychiatry
Mini-reviewRole of brain-derived neurotrophic factor in eating disorders: Recent findings and its pathophysiological implications
Introduction
People suffering from eating disorders exhibit serious disturbances in eating behavior, such as extreme and unhealthy reduction of their food intake or severe overeating, as well as feelings of distress about, or extreme concern over, their body shape or weight. Eating disorders frequently develop during adolescence or early adulthood, but some studies have reported their onset during childhood or later in adulthood. Eating disorders affect some 1–3% of women in the United States (Becker et al., 1999, Kaye et al., 2000, Walsh and Devlin, 1998, Fairburn and Harrison, 2003, Klein and Walsh, 2004, Polivy and Herman, 2002). The major types of eating disorders are anorexia nervosa (AN) and bulimia nervosa (BN) that are diagnosed by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Ed. (DSM-IV; American Psychiatric Association; Table 1). The etiology of eating disorders is presumed to be complex, and to be influenced by multiple developmental, social, and biological processes (Becker et al., 1999, Kaye et al., 2000, Fairburn and Harrison, 2003, Walsh and Devlin, 1998, Klein and Walsh, 2004).
Brain-derived neurotrophic factor (BDNF) is recognized as a critical regulator in the survival, differentiation, and outgrowth of select peripheral and central neurons during development and in adulthood, and is also implicated in the synaptic plasticity of such brain functions as learning and memory (Snider, 1994, Thoenen, 2000, Schinder and Poo, 2000, Huang and Reichardt, 2001, Malcangio and Lessmann, 2003, Mattson, 2002, Mattson et al., 2003, Mattson et al., 2004, Lu, 2003a). Several lines of evidence suggest that BDNF plays an important role in the pathophysiology of psychiatric diseases, including mood disorders, and in the mechanism of action of therapeutic agents (Duman et al., 1997, Duman, 2002, Tamminga et al., 2002, Manji et al., 2003, Nestler et al., 2002, Coyle and Duman, 2003, Green and Craddock, 2003, Angelucci et al., 2004, Hashimoto et al., 2004).
Section snippets
Animal studies
There is also evidence supporting the critical role of BDNF in regulating eating behaviors in animals. For example, heterozygous BDNF (±) knock-out mice (e.g., approximately 50% levels of BDNF of wild-type mice) show enhanced inter-male aggressiveness and hyperphagia accompanied by significant weight gain in early adulthood, and these behavioral abnormalities have been correlated with 5-hydroxytryptamine (5-HT) dysfunction in the brain, since these behavioral abnormalities were ameliorated by
Human serum
Based on the role BDNF plays in eating behavior, it is important to assess the potential contribution of BDNF to the pathophysiology of eating disorders. Recently, we found that serum levels of BDNF in female patients with AN or BN were significantly decreased compared with those of age-matched normal control subjects, and we also found a significant positive correlation between the Bulimic Investigatory Test, Edinburgh (BITE) symptom scale (the severity of symptoms of bulimia), and the
Concluding remarks
It is well known that disturbances in neuronal systems have been found to play a role in the modulation of feeding, mood, and impulse control. These neuronal systems include neuropeptides [corticotropin-releasing hormone (CRH), opioids, neuropeptide-Y (NPY), peptide YY (PYY), vasopressin, oxytocin, cholecystokinin (CCK), leptin, and ghrelin] and monoamines (5-HT, dopamine, norepinephrine) (Barbarich et al., 2003). Recent studies with positron emission tomography (PET) demonstrated that altered
Acknowledgement
This study was supported by a Grant-in Aid for the Ministry of Health, Labor and Welfare of Japan (KH).
References (55)
- et al.
Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia
Prog. Brain Res.
(2004) - et al.
Neurotrophins: to cleave or not to cleave
Neuron
(2002) - et al.
Finding the intracellular signaling pathways affected by mood disorder treatments
Neuron
(2003) - et al.
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function
Cell
(2003) - et al.
Eating disorders
Lancet
(2003) - et al.
Reduced 5-HT2A receptor binding after recovery from anorexia nervosa
Biol. Psychiatry
(2002) - et al.
Critical role of brain-derived neurotrophic factor in mood disorders
Brain Res. Brain Res. Rev.
(2004) - et al.
Candidate gene polymorphisms in eating disorders
Eur. J. Pharmacol.
(2000) - et al.
Eating disorders: clinical features and pathophysiology
Physiol. Behav.
(2004) Pro-region of neurotrophins: role in synaptic modulation
Neuron
(2003)